Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
about
Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target.Human IL-6RhiTIGIT- CD4+CD127lowCD25+ T cells display potent in vitro suppressive capacity and a distinct Th17 profile.The role of IL-6 in host defence against infections: immunobiology and clinical implications.The dichotomous nature of T helper 17 cells.The role of ADAM17 in the T-cell response against bacterial pathogens.JunB promotes Th17 cell identity and restrains alternative CD4+ T-cell programs during inflammation.Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology.Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts.The spectrum of T cell metabolism in health and disease.IL-27 - a double agent in the IL-6 family.The balance between Treg and TH17 cells: CD11b and interleukin-6.Old dog, new tricks: IL-6 cluster signaling promotes pathogenic TH17 cell differentiation.A Role for Soluble IL-6 Receptor in Osteoarthritis.The role of TGF-β in Th17 differentiation.Genetic ablation of histone deacetylase 2 leads to lung cellular senescence and lymphoid follicle formation in COPD/emphysema.Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice.Neutrophils in Tissue Trauma of the Skin, Bone, and Lung: Two Sides of the Same Coin.Establishment and Characterization of a Functionally Competent Type 2 Conventional Dendritic Cell LineControl of Listeria monocytogenes infection requires classical IL-6 signaling in myeloid cellsTGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of T17 cells by an AHR-independent mechanism
P2860
Q33774610-B3428F2C-0F5D-47E6-95C3-0207E75E56ADQ33800947-71D5DAA8-D68D-4259-AD6F-2F095F3E9A52Q38725223-BB3100C0-A3E6-460D-BCD3-70238C382176Q39337496-ED80B095-7670-4245-8936-53B3494FBEA7Q40064445-50CFC249-1094-46E8-9EE8-34653A61514AQ40086551-4076A61C-829F-4C1F-A042-E3A8340CEBA5Q41929315-218A4D5F-85BB-48CF-BBC9-35C8163460DDQ47121377-36469358-5FF0-4082-AECF-C7145BD5B791Q47121775-52DD835D-5196-47F6-9100-CECF3E0C9AC9Q49853005-E03CB0F1-EA02-4638-8866-2A0B22DAAAC6Q50045633-4524C61F-6D9D-4C9D-AAA5-6B39CD9AE77BQ51067514-DB84FC00-BB57-44CB-9611-FD3059B5332DQ51255626-7ACC6DDA-5DE1-47D3-AE87-FB3C5C1D32C7Q52404707-F09F69A2-FD91-4CFD-866A-65D37F6EF855Q52570914-3A34D13E-781F-4F0E-B162-65CA71392A98Q52720696-21A4C508-F5C2-4C6F-A25F-8E3EE0A0AA6AQ54209318-1772E901-30B2-4E7A-B0FA-B1F17B93A9DEQ55049931-E5349267-DBDB-49DC-B8A8-688FD34FBE82Q58705648-8FE5FD50-C949-4F61-955B-D0F0564A7787Q58782375-3253EC48-0BD5-4F24-99C0-9AC75100D7DCQ59137908-47C9E170-DA83-4CF8-9CF7-7AB7319A9A6D
P2860
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Trans-presentation of IL-6 by ...... iming of pathogenic TH17 cells
@en
Trans-presentation of IL-6 by ...... ming of pathogenic TH17 cells.
@nl
type
label
Trans-presentation of IL-6 by ...... iming of pathogenic TH17 cells
@en
Trans-presentation of IL-6 by ...... ming of pathogenic TH17 cells.
@nl
prefLabel
Trans-presentation of IL-6 by ...... iming of pathogenic TH17 cells
@en
Trans-presentation of IL-6 by ...... ming of pathogenic TH17 cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
Trans-presentation of IL-6 by ...... iming of pathogenic TH17 cells
@en
P2093
Andrew L Croxford
Bernhard Hemmer
Christiane Gasperi
Harald S Bartsch
Helmut Blum
Karl Sotlar
Katja Möller-Hackbarth
Marc Schmidt-Supprian
Marina Herwerth
Mohamed Oukka
P2860
P356
10.1038/NI.3632
P407
P577
2016-11-28T00:00:00Z